- Home
- Clinical Trials
Cardiovascular Study Melbourne 2023
Cardiovascular Study
Sunshine Melbourne
Are you at high risk for a heart attack or stroke but have never experienced one?
Momentum Clinical Research are evaluating a potential new treatment that aims to prevent first major cardiovascular events in individuals with elevated levels of Lipoprotein(a) – a type of cholesterol that can increase your risk of heart disease.
Participants will be reimbursed to cover for travel, parking, meals and other expenses associated with the research project.
This study will be conducted at Momentum Sunshine.
Description
What to expect
Study details
Ages
50 years or older
Duration
Approximately 5.5 years
Compensation
Participants will be reimbursed to cover for travel, parking, meals and other expenses associated with the research project
Eligibility Criteria
You may be eligible to join this study if you:
- Are aged 50 years or older
- Have high lipoprotein(a) levels – this will be checked with a simple blood test
- Have been on stable cholesterol-lowering treatment for at least four weeks
- Have risk factors or signs of heart disease – e.g. high blood pressure, diabetes, kidney disease, current tobacco smoker, atherosclerosis.
Some medical conditions may make you ineligible, such as a past heart attack, stroke, or severe kidney, liver, or heart issues.
Other criteria will apply.
Locations
Description
Cardiovascular disease (CVD) is a long-term condition that affects the heart and blood vessels. It often develops quietly overtime and increases the risk of serious cardiovascular events such as heart attacks and strokes.
For some people, this risk exists despite living a healthy lifestyle. They exercise, eat well, and do everything "right" - but still face danger due to factors beyond their control.
One of these factors is elevated lipoprotein(a), or Lp(a) – a genetic condition that cannot be improved through lifestyle modifications like diet or exercise.
Many people don’t know if they have high Lp(a), because it’s not routinely tested in standard cholesterol panels. It’s considered a form of high cholesterol, but it behaves differently. The medications typically used to lower high cholesterol do not effectively reduce Lp(a) levels. As a result, individuals with elevated Lp(a) may remain unaware of their increased risk.
There are currently no approved treatments for high Lp(a). This lack of options can be deeply frustrating and emotionally draining for those trying their best to stay healthy.
Momentum Clinical Research is exploring new treatments that target Lp(a) and reduce the risk of first-time cardiovascular events – offering new hope to people living with this risk.
What to expect
This research study aims to elevate a potential new treatment designed to reduce the risk of a first major cardiovascular event such as a heart attack or stroke, in people with elevated cardiovascular risk. The treatment specially targets Lipoprotein(a), a genetic risk factor that current medications do not directly address.
Participants will be randomly assigned to receive either the study treatment or a placebo. Throughout the study, participants will attend regular visits for health monitoring and support from out experienced medical team. Participants will also be on stable and optimized lipid-lowering therapy.
Register your interest now to find out if you are eligible to participate in this study and help develop potential new treatment options for those living with elevated Lp(a) levels and are at higher risk of first time cardiovascular events.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.